Smith Susan Laura 4
4 · Y-mAbs Therapeutics, Inc. · Filed Mar 7, 2024
Insider Transaction Report
Form 4
Smith Susan Laura
SVP & CCO
Transactions
- Sale
Common Stock
2024-03-05$16.55/sh−1,682$27,837→ 33,918 total
Footnotes (1)
- [F1]Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.